Literature DB >> 9324146

A prospective randomized comparison of transhiatal and transthoracic resection for lower-third esophageal carcinoma.

K M Chu1, S Y Law, M Fok, J Wong.   

Abstract

BACKGROUND: The question whether transhiatal (TH) or transthoracic (TT) resection is most suited for the extirpation of an esophageal cancer remains unresolved. The present study compared the two approaches in a prospective randomized manner. PATIENTS AND METHODS: Thirty-nine patients with carcinoma of the lower third of the esophagus who were clinically fit for either TH or TT resection were prospectively randomized to TH (20 patients) and TT (19 patients) resection. Patients of the two groups were comparable in age, sex, preoperative tumor staging, and pulmonary and cardiac risks for surgery.
RESULTS: There was no significant difference in the amount of blood loss between the two groups although intraoperative hypotension (systolic <80 mm Hg) occurred more frequently in the TH group (P <0.001). The mean operating time for the TH and TT groups were 174 minutes and 210 minutes, respectively (P <0.001). There was no difference in postoperative ventilatory requirements, cardiopulmonary complication rates, and, mean hospital stay between the two groups. There was no 30-day mortality in either group but there were 3 hospital deaths in the TH group from bronchopneumonia (2 patients) and disseminated malignancy (1 patient). The median survival rates were 16 and 13.5 months, respectively, for the TH and TT groups (P = NS).
CONCLUSIONS: Although there was no demonstrable statistical difference in results between TH and TT approaches, the TT approach is preferred as it allowed for a more controlled operation.

Entities:  

Mesh:

Year:  1997        PMID: 9324146     DOI: 10.1016/s0002-9610(97)00105-0

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  49 in total

1.  Transthoracic approach is associated with increased incidence of atrial fibrillation after esophageal resection.

Authors:  Kush R Lohani; Kalyana C Nandipati; Sarah E Rollins; Katharina Fetten; Tommy H Lee; Pradeep K Pallati; Se Ryung Yamamoto; Sumeet K Mittal
Journal:  Surg Endosc       Date:  2014-11-01       Impact factor: 4.584

Review 2.  Multimodality therapy for gastroesophageal cancers.

Authors:  Kenneth K Wang
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

3.  Esophagogastric anastomosis with invagination into stomach: New technique to reduce fistula formation.

Authors:  Alexandre Cruz Henriques; Carlos Alberto Godinho; Roberto Saad; Daniel Reis Waisberg; Aline Biral Zanon; Manlio Basilio Speranzini; Jaques Waisberg
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

Review 4.  Current management of esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

5.  Levels of evidence and grades of recommendations in general thoracic surgery.

Authors:  Andrew J Graham; Gary Gelfand; Sean D McFadden; Sean C Grondin
Journal:  Can J Surg       Date:  2004-12       Impact factor: 2.089

6.  Transthoracic versus transhiatal esophagectomy for esophageal carcinoma: experience from a single tertiary care institution.

Authors:  Nadeem UlNazeer Kawoosa; Abdul Majeed Dar; Mukand Lal Sharma; Abdul Gani Ahangar; Ghulam Nabi Lone; Mohammad Akbar Bhat; Shyam Singh
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

7.  Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management.

Authors:  R T Poon; S Y Law; K M Chu; F J Branicki; J Wong
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

Review 8.  A personal perspective on controversies in the surgical management of oesophageal cancer.

Authors:  J McK Manson; W D Beasley
Journal:  Ann R Coll Surg Engl       Date:  2014-11       Impact factor: 1.891

9.  Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.

Authors:  Donald E Low; Sonia Kunz; Drew Schembre; Henry Otero; Tom Malpass; Alex Hsi; Guobin Song; Richard Hinke; Richard A Kozarek
Journal:  J Gastrointest Surg       Date:  2007-08-31       Impact factor: 3.452

10.  Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.

Authors:  Sheraz R Markar; Henner Schmidt; Sonia Kunz; Artur Bodnar; Michal Hubka; Donald E Low
Journal:  J Gastrointest Surg       Date:  2014-04-29       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.